Company Dossier · Real Estate
Healthpeak Properties
- S&P 500
- Russell 1000
What Healthpeak Properties is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $0.72 billion, up 22% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to December 31, 2016: $0.76 billion, down 9.5% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to December 31, 2016: $0.46 billion, up 21% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to December 31, 2025: $0.10 billion.SEC EDGAR filings (10-K)
- Long-term debt issued in the fiscal year to December 31, 2015: $1.94 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (August 5, 2026): sentiment 0.60 on a −1 to +1 scale (mixed), confidence 0.70 of 1.Palanor Discourse
- Guidance in the last 90 days: 3 outlook figures raised, 0 lowered, 0 held.Guidance Ledger (8-K results releases)
- Latest annual report (filed February 3, 2026): 3 risk factors added, 3 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q2 2026: $0.2 million on the open market.SEC Form 4
- 767 institutional managers reported a position at June 30, 2026 (+7 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 1.U.S. Department of Labor (OFLC)
Company Posture
How Company Posture is measured →What Healthpeak Properties is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Expanding ↔ Retrenching
Withheld: 50% of the evidence is readable at this date (needs 60%).
- Capital spending—
- Debt raised—
- Buybacks vs capex—
- Hiring filings50th pct
- Deals and private raises38th pct
- Patent publications50th pct
Confident ↔ Hedging
Mixed
- Call sentiment54th pct
- Call confidence37th pct
- Guidance changes71st pct
- Risk factors added36th pct
- Insider open-market trades26th pct
- + Guidance changes
- − Insider open-market trades
- − Call confidence
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver40th pct
- Stress filings50th pct
Credit
How these are built →Healthpeak Properties's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$10.0B
- Due within a year $1.4B
- Longer term $8.7B
- Default point $5.7B (short + ½ long)
Finance leases included · Jun 30, 2026 filing
Bonds priced, last 12 months
None
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name Healthpeak Properties, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- NeutralHealthpeak Properties (DOC) Maintains Monthly Dividend with 6.28% Yield Amid Updated 2026 FFO Guidance
gurufocus.com · via Marketaux · Oct 2, 2026
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 1, 2026LobbyingLobbying report (MARSHALL BRACHMAN)third_quarter 2026 · $0.1 million
- Jul 1, 2026LobbyingLobbying report (MARSHALL BRACHMAN)second_quarter 2026 · $0.1 million
- May 4, 20268-KShareholder vote resultsItem 5.07
- Apr 3, 2026LobbyingLobbying report (MARSHALL BRACHMAN)first_quarter 2026 · $0.1 million
- Mar 23, 20268-KMaterial agreement signedItem 1.01
- Feb 3, 202610-KAnnual report (10-K)3 risk factors added, 3 removed
- Jan 2, 2026LobbyingLobbying report (MARSHALL BRACHMAN)fourth_quarter 2025 · $0.1 million
- Nov 24, 2025Trademark
- Oct 30, 2025Trademark
- Oct 17, 2025Trademark
- Oct 2, 2025LobbyingLobbying report (MARSHALL BRACHMAN)third_quarter 2025 · $0.1 million
- Jul 2, 2025LobbyingLobbying report (MARSHALL BRACHMAN)second_quarter 2025 · $0.1 million
- Apr 28, 20258-KDirector or officer changeItem 5.02
- Apr 28, 20258-KShareholder vote resultsItem 5.07
- Apr 24, 20258-KDirector or officer changeItem 5.02
- Apr 7, 20258-KDirector or officer changeItem 5.02
- Apr 4, 2025LobbyingLobbying report (MARSHALL BRACHMAN)first_quarter 2025 · $0.0 million
- Feb 4, 202510-KAnnual report (10-K)2 risk factors added, 12 removed
- Feb 3, 20258-KDirector or officer changeItem 5.02
- Jan 1, 2025LobbyingLobbying report (MARSHALL BRACHMAN)fourth_quarter 2024 · $0.0 million
- Dec 9, 20248-KMaterial agreement signedItem 1.01
- Feb 9, 202410-KAnnual report (10-K)22 risk factors added, 0 removed
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Medical Properties Trust MPT | $1.0B | — | Mar 31, 2026 |
| American Healthcare REIT AHR | $2.3B | — | Jun 30, 2026 |
| Ventas VTR | $6.4B | — | Jun 30, 2026 |
| Welltower WELL | $9.4B | — | Mar 31, 2026 |
| EPR Properties EPR | $0.7B | −$0.1B | Jun 30, 2026 |
| EastGroup Properties EGP | $0.8B | — | Jun 30, 2026 |
| First Industrial Realty Trust FR | $0.8B | — | Jun 30, 2026 |
| Rayonier RYN | $0.7B | — | Mar 31, 2026 |